Werner coordination chemistry and neurodegeneration
- PMID: 22952002
- DOI: 10.1039/c2cs35236b
Werner coordination chemistry and neurodegeneration
Abstract
Neurodegenerative diseases are capturing the world's attention as being the next set of diseases we must tackle collectively. Not only are the patients experiencing gradual cognitive and physical decline in most cases, but these diseases are fatal with no prevention currently available. As these diseases are progressive, providing care and symptom treatment for the ageing population is becoming both a medical and a financial challenge. This review discusses how Werner coordination chemistry plays a role in three diseases - those of Alzheimer's, Parkinson's, and prions. Metal ions are considered to be involved in these diseases in part via their propensity to cause toxic aggregation of proteins. First, the coordination of metal ions, with emphasis on copper(II), to metalloproteins that are hallmarks of these diseases - amyloid β, α-synuclein, and prion, respectively - will be discussed. We will present the current understanding of the metal coordination environments created by the amino acids of these proteins, as well as metal binding affinity. Second, a diverse set of examples of rationally designed metal chelators to outcompete this deleterious binding will be examined based on coordination mode and affinity toward bio-relevant metal ions. Overall, this review will give a general overview of protein and metal chelator coordination environments in neurodegenerative diseases.
Similar articles
-
Copper(I/II), α/β-Synuclein and Amyloid-β: Menage à Trois?Chembiochem. 2015 Nov 2;16(16):2319-28. doi: 10.1002/cbic.201500425. Epub 2015 Sep 25. Chembiochem. 2015. PMID: 26338312
-
Structural characterization of a high affinity mononuclear site in the copper(II)-α-synuclein complex.J Am Chem Soc. 2010 Dec 29;132(51):18057-66. doi: 10.1021/ja103338n. Epub 2010 Dec 8. J Am Chem Soc. 2010. PMID: 21141829
-
Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation.J Am Chem Soc. 2008 Sep 3;130(35):11801-12. doi: 10.1021/ja803494v. Epub 2008 Aug 9. J Am Chem Soc. 2008. PMID: 18693689
-
Metalloproteomics and metal toxicology of α-synuclein.Metallomics. 2010 Jun;2(6):378-92. doi: 10.1039/b926659c. Epub 2010 May 13. Metallomics. 2010. PMID: 21072383 Review.
-
Insights into the thermodynamics of copper association with amyloid-β, α-synuclein and prion proteins.Metallomics. 2011 Mar;3(3):262-6. doi: 10.1039/c0mt00052c. Epub 2010 Nov 29. Metallomics. 2011. PMID: 21116546 Review.
Cited by
-
Structure-mechanism-based engineering of chemical regulators targeting distinct pathological factors in Alzheimer's disease.Nat Commun. 2016 Oct 13;7:13115. doi: 10.1038/ncomms13115. Nat Commun. 2016. PMID: 27734843 Free PMC article.
-
A Metallo Pro-Drug to Target CuII in the Context of Alzheimer's Disease.Chemistry. 2018 Apr 6;24(20):5095-5099. doi: 10.1002/chem.201706049. Epub 2018 Feb 16. Chemistry. 2018. PMID: 29334419 Free PMC article.
-
A Trishistidine Pseudopeptide with Ability to Remove Both CuΙ and CuΙΙ from the Amyloid-β Peptide and to Stop the Associated ROS Formation.Chemistry. 2017 Dec 1;23(67):17078-17088. doi: 10.1002/chem.201703429. Epub 2017 Nov 9. Chemistry. 2017. PMID: 28846165 Free PMC article.
-
Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.J Alzheimers Dis. 2021;82(s1):S335-S357. doi: 10.3233/JAD-200185. J Alzheimers Dis. 2021. PMID: 32568200 Free PMC article. Review.
-
Chelation-induced diradical formation as an approach to modulation of the amyloid-β aggregation pathway.Chem Sci. 2015 Feb 1;6(2):1018-1026. doi: 10.1039/c4sc01979b. Epub 2014 Oct 30. Chem Sci. 2015. PMID: 29560189 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
